<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Pharmaceutical and Biomedical Research</title>
<title_fa></title_fa>
<short_title>Pharm Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://pbr.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-4486</journal_id_issn>
<journal_id_issn_online>2423-4494</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/pbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Synthesis of Pyrazolo[1,2-b]phthalazine-5,10-dione Derivatives: A New Class of α –Glucosidase Inhibitors</title>
	<subject_fa>شیمی دارویی</subject_fa>
	<subject>Medical Chemistry</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Hyperglycemia is a metabolic disorder that refers to an increase in blood sugar in diabetic patients. &amp;alpha;-Glucosidase has been introduced as a membrane-bound enzyme, and it is the main enzyme for carbohydrate digestion in some parts of the intestine. Inhibition of &amp;alpha; -glucosidase enzyme activity is a reliable approach to control post-prandial hyperglycemia condition.&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: In this study, a series of Pyrazolo[1,2-b]phthalazine-5,10-dione derivatives 5a&amp;ndash;t were synthesized via a multicomponent reaction and evaluated as new inhibitors for &amp;alpha;-glucosidase.&lt;br&gt;
&lt;strong&gt;Methods:&lt;/strong&gt; The biological activity of the synthesized compounds was studied using a source of the &amp;alpha;-glucosidase enzyme (EC3.2.1.20, Saccharomyces cerevisiae) at 20 U/mg concentration.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Results:&lt;/strong&gt; Four compounds showed higher &amp;alpha;-glucosidase inhibitory activity in comparison to a standard, i.e., Acarbose. Compound 5q displays the most potent &amp;alpha;-glucosidase inhibitory activity (IC50 = 155.4 &amp;plusmn; 6.0 &amp;mu;M).&amp;nbsp;&lt;br&gt;
Conclusion: In conclusion, some of the synthesized compounds, including heterocyclic core molecules, have shown remarkable activity that could be considered as subjects for the development of new, more efficient inhibitors of the &amp;alpha;-glucosidase enzyme.&amp;nbsp;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>α-Glucosidase inhibitors, Pyrazolophthalazine, Malononitrile, Aldehyde</keyword>
	<start_page>121</start_page>
	<end_page>132</end_page>
	<web_url>http://pbr.mazums.ac.ir/browse.php?a_code=A-10-718-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Hosseinpoor Tehrani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>m250_tehrani@yahoo.com</email>
	<code>10031947532846006657</code>
	<orcid>10031947532846006657</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of chemistry, Payame Noor University (PNU), P.O Box 19395-4697, Tehran,Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Ahmad</first_name>
	<middle_name></middle_name>
	<last_name>Mirshokraie</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a.mirshokraie@gmail.com</email>
	<code>10031947532846006658</code>
	<orcid>10031947532846006658</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of chemistry, Payame Noor University (PNU), P.O Box 19395-4697, Tehran,Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mehdi</first_name>
	<middle_name></middle_name>
	<last_name>Khoobi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mehdi.khoobi@gmail.com</email>
	<code>10031947532846006659</code>
	<orcid>10031947532846006659</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biomaterials, The Institue of Pharmaceutical Sciences(TIPS), Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohsen</first_name>
	<middle_name></middle_name>
	<last_name>Amini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>moamini@tums.ac.ir</email>
	<code>10031947532846006660</code>
	<orcid>10031947532846006660</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Medicinal Chemistry, Development Research Center, School of Pharmacy, and Drug Design, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
